on 16 Jun 2010
Last Applicant/ Owned by
AMBRILIA BIOPHARMA INC.
1000 Chemin du GolfVerdun
QUEBEC
CA
H3E1H4
Serial Number
1282195 filed on 7th Dec 2005
Correspondent Address
BCF S.E.N.C.R.L./BCF LLP
1100, boul. René-Lévesque Ouest25e ÉtageMontréal
QUÉBEC
CA
H3B5C9
Trademark usage description
pharmaceutical research and development services in the field of therapeutic and diagnostic products; manufacturing services for others in the field o Read MoreCIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
1282195
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 7 on 16th Jun 2010 | Abandoned - Subsection 40(3) |
Submitted for opposition 51 on 27th Nov 2009 | Allowance Notice Sent |
Submitted for opposition 50 on 27th Nov 2009 | Allowed |
Submitted for opposition 42 on 12th Aug 2009 | Advertised |
Submitted for opposition 26 on 23rd Jul 2009 | Approved |
Submitted for opposition 27 on 4th Jun 2009 | Approval Notice Sent |
Submitted for opposition 12 on 30th Jan 2009 | Extension of Time |
Submitted for opposition 12 on 19th Aug 2008 | Extension of Time |
Submitted for opposition 12 on 8th Feb 2008 | Extension of Time |
Submitted for opposition 12 on 30th Jul 2007 | Extension of Time |